Literature DB >> 17220628

Clinical and neuropsychological features associated with structural imaging patterns in patients with mild cognitive impairment.

Roberta Rossi1, Cristina Geroldi, Lorena Bresciani, Cristina Testa, Giuliano Binetti, Orazio Zanetti, Giovanni B Frisoni.   

Abstract

AIM: To describe the clinical and neuropsychological features of mild cognitive impairment (MCI) patients with medial temporal atrophy (MTA), white matter hyperintensities (WMH), both, and neither and to assess whether the rate of progression differs among groups.
METHODS: Ninety-five MCI patients were divided into 4 groups based on the presence of MTA and WMH: 29 were MTA- WMH-, 11 MTA- WMH+, 23 MTA+ WMH-, and 32 MTA+ WMH+. MCI patients were compared with 30 normal subjects. MTA and WMH were assessed with MR-based visual rating scales. Subjects underwent an extensive clinical and neuropsychological investigation. Fifty-six underwent follow-up evaluation.
RESULTS: MTA- WMH- had relatively good neuropsychological performance, little vascular and physical comorbidity. MTA- WMH+ performed poorly only on executive neuropsychological tests. MTA+ WMH- patients had poor neuropsychological performances (mainly on memory tests), high physical and vascular comorbidity. MTA+ WMH+ were impaired in neuropsychological performances, had a high number of physical diseases and severe vascular comorbidity. On follow-up, 25% of MTA+ WMH- and 32% of MTA+ WMH+ and none in MTA- WMH- and in MTA- WMH+ converted to dementia (p = 0.05, log rank test).
CONCLUSION: Structural neuroimaging can identify subgroups of MCI patients with specific clinical and neuropsychological features.

Entities:  

Mesh:

Year:  2007        PMID: 17220628     DOI: 10.1159/000098543

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  9 in total

1.  Subclinical cerebrovascular disease in mild cognitive impairment.

Authors:  J A Luchsinger; A M Brickman; C Reitz; S J Cho; N Schupf; J J Manly; M X Tang; S A Small; R Mayeux; C DeCarli; T R Brown
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

2.  Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study.

Authors:  Angela L Jefferson; Alexa S Beiser; Jayandra J Himali; Sudha Seshadri; Christopher J O'Donnell; Warren J Manning; Philip A Wolf; Rhoda Au; Emelia J Benjamin
Journal:  Circulation       Date:  2015-02-19       Impact factor: 29.690

3.  Adverse vascular risk is related to cognitive decline in older adults.

Authors:  Angela L Jefferson; Timothy J Hohman; Dandan Liu; Shereen Haj-Hassan; Katherine A Gifford; Elleena M Benson; Jeannine S Skinner; Zengqi Lu; Jamie Sparling; Emily C Sumner; Susan Bell; Frederick L Ruberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 4.  Cardiac output as a potential risk factor for abnormal brain aging.

Authors:  Angela L Jefferson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment.

Authors:  Ningnannan Zhang; Xiaowei Song; Yunting Zhang
Journal:  Dement Geriatr Cogn Disord       Date:  2012-07-02       Impact factor: 2.959

6.  Multi-modal imaging predicts memory performance in normal aging and cognitive decline.

Authors:  K B Walhovd; A M Fjell; A M Dale; L K McEvoy; J Brewer; D S Karow; D P Salmon; C Fennema-Notestine
Journal:  Neurobiol Aging       Date:  2008-10-05       Impact factor: 4.673

7.  Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.

Authors:  Katie E Osborn; Jonathan M Alverio; Logan Dumitrescu; Kimberly R Pechman; Katherine A Gifford; Timothy J Hohman; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 8.  Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

Authors:  Kurt A Jellinger; Bernd Janetzky; Johannes Attems; Elisabeth Kienzl
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

9.  Differential effects of a computerized cognitive stimulation program on older adults with mild cognitive impairment according to the severity of white matter hyperintensities.

Authors:  Leila Djabelkhir-Jemmi; Ya-Huei Wu; Marouane Boubaya; Fabienne Marlats; Manon Lewis; Jean-Sébastien Vidal; Hermine Lenoir; Benoit Charlieux; Baptiste Isabet; Anne-Sophie Rigaud
Journal:  Clin Interv Aging       Date:  2018-08-30       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.